Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer

Veteran CFO appointment underscores the Company’s commitment to building a strong leadership team as it advances its clinical ...
Fierce Pharma

Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028

With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...
Fierce Pharma

Biomanufacturer Antheia bolsters commercial drug ingredients prospects with TAPI alliance

After several notable moves to grow the reach of its biomanufacturing platform in recent months, Antheia is linking arms with ...
Pharmaceutical Technology

Eco-design: Shaping the future of pharma packaging

Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and ...
Fierce Biotech

'We're built for it': Why Cytokinetics doesn't want Big Pharma support to help it supersede Camzyos

Cytokinetics may be counting down the days until the FDA decides whether to approve its cardiovascular drug aficamten. | ...
pharmaphorum

Changing Faces - Pharma and biotech - October 2025

Mosaic Therapeutics welcomes new CEO. Former Cimeio Therapeutics CEO Thomas Fuchs has taken the helm at Mosaic Therapeutics, ...

Agios Pharma: Study Fail May Affect Mitapivat TDT Approval - Expect More Volatility

Agios Pharmaceuticals, Inc. drops after mixed Phase 3 mitapivat results in Sickle Cell Disease. Click here to find out why ...
Cantech Letter

Piramal Pharma Solutions’ Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal ...

Nasus Pharma, Ltd.: Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer

Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma", "Nasus" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative ...
Medical Dialogues

Piramal Pharma Solutions Grangemouth facility gets updated MHRA GMP certificates

Mumbai: Piramal Pharma Solutions, a global Contract Development and Manufacturing Organization (CDMO) and part of Piramal ...
pharmaphorum

The importance of globalisation for patient access

Alongside scientific innovation, ESMO 2025 emphasised the need for global collaboration in regulatory alignment and clinical ...

Alvotech S.A.: Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz, a First-in-Market Biosimilar to Simponi (golimumab)

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited ("Advanz Pharma"), a U ...